ME Therapeutics Holdings Inc. ("ME Therapeutics" or the "Company") (CSE: METX) (FSE: Q9T), a publicly listed biotechnology ...

Leveraging its integrated "design-synthesis-quality control" system, Creative Biolabs is overcoming bottlenecks in mRNA ...

Researchers from the Wilmer Eye Institute, Johns Hopkins Medicine Center for Nanomedicine - which designs nanotechnology-based platforms for clinical translation across specialties - developed a ...

Genespire is looking to take its single-dose gene therapy, GENE202, to the clinic by the end of 2026, where it will be evaluated as a treatment for rare metabolic disease, methylmalonic acidaemia.

COVID pivot at Davos, betting on personalised mRNA cancer therapies, new vaccine launches, and AI-led drug development to drive its next growth phase.

Johns Hopkins researchers developed lipid nanoparticles to deliver therapeutic mRNA directly to the endometrium in mice. The ...

At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP). The ...

Starcloud’s founders — CEO Philip Johnston, chief technology officer Ezra Feilden and chief engineer Adi Oltean — wear protective gear as they check out the startup’s Starcloud-1 satellite before ...

Department of Obstetrics, The Affiliated Dongguan Songshan Lake Central Hospital, Guangdong Medical University, Dongguan, China Objective: To investigate the construction and clinical application ...

Interest in intensified manufacturing is driving innovation in downstream technologies, according to the team behind a new predictive freeze-drying model designed with continuous processes in mind.

Niral Shah does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...